WAYPOINT BIO
Waypoint Bio is a biotechnology company developing therapeutic treatments for rare genetic diseases
WAYPOINT BIO
Industry:
Biotechnology
Founded:
2021-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.waypointbio.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Current Employees Featured
Founder
Official Site Inspections
http://www.waypointbio.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Waypoint Bio"
ABOUT - Waypoint
We are pioneering high throughput in vivo testing to develop novel cell therapies for solid tumors, autoimmune diseases, and beyond.. Our platform uses ultra-high resolution spatial multi-omics …See details»
OUR TEAM - Waypoint Bio
As experts in spatial biology, computational biology, and machine learning, our team brings experience and novel approaches to solving the greatest challenges in cell therapy design and …See details»
Waypoint Bio - Crunchbase Company Profile & Funding
Optimizing cell therapy with spatial biology. Waypoint Bio launched with $14.5 million to enhance drug discovery using in vivo spatial pooled screening technology.See details»
Waypoint Bio - LinkedIn
Waypoint Bio | 6,444 followers on LinkedIn. Optimizing cell therapy with spatial biology | Waypoint Bio is a VC-backed biotech startup building the next generation of cell therapies for solid tumors.See details»
Waypoint Bio, New York - LifeScienceHistory.com
Waypointbio.com. 180 Varick Street, 6th Floor. New York, NY 10014. Company Info Year Established 2021. Contacts Xinchen Wang,Ph.D. Co-Founder & CEO David Phizicky, Ph.D. …See details»
Waypoint Bio - VentureRadar
Website: https://waypointbio.com/ Develops innovative cell therapies for solid tumors using proprietary spatial pooled screening tech and lab-in-the-loop approach ...See details»
Waypoint Bio 2025 Company Profile: Valuation, …
Waypoint Bio General Information Description. Developer of novel cell therapy platform designed to combat solid tumors of cancer. The company's platform uses spatial multi-omics which is performed by proprietary approaches using novel …See details»
Waypoint Bio - Craft
Waypoint Bio is a biotech company that develops cell therapies for solid tumors and autoimmune diseases. Its platform uses spatial multi-omics technology that combines computer vision, cell …See details»
Waypoint Bio - Work in biotech
Waypoint Bio is utilizing its spatial biology platform to identify and engineer exosomes that are targeted to tumor cells. Spatial biology allows scientists to study cells in their native tissue …See details»
OUR PLATFORM - Waypoint Bio
Leveraging advances in computer vision, in silico protein design, and pooled screening, we can achieve groundbreaking deep phenotyping across a multitude of cell therapy designs, using …See details»
Waypoint Bio Launches with $14.5M to Revolutionize Solid Tumor …
Jun 29, 2024 waypointbio.com. Editorial Opinion: Advancing Therapeutic Frontiers Through Innovative Funding. Waypoint Bio’s successful $14.5 million seed funding signifies a pivotal …See details»
Waypoint Bio Launches with $14.5M to Turbocharge Drug …
Jun 28, 2024 NEW YORK – Waypoint Bio (aka “Waypoint”), a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening …See details»
Waypoint Bio - VentureRadar
"Waypoint Bio, founded by David Phizicky, Ph.D., and Xinchen Wang, Ph.D., in 2021, is a startup working to develop novel approaches to treat dosage-sensitive diseases such as …See details»
CAREERS | Waypoint
The ideal candidate will have extensive expertise in immunology, including a deep understanding of either regulatory T cells (Tregs) or the design of engineered T cell therapies (e.g. CAR-Treg, …See details»
Waypoint Bio: $14.5 Million Seed Round Closed To Advance Drug …
Jun 29, 2024 Waypoint Bio, a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology, announced $14.5 million in seed …See details»
Waypoint Bio Launches with $14.5M to Turbocharge Drug …
Jun 28, 2024 NEW YORK– Waypoint Bio (aka “Waypoint”), a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology, today …See details»
MassBio Recognizes Life Sciences Companies, Leaders with …
Mar 26, 2025 CAMBRIDGE, MA (Wednesday, March 26, 2025)—Today, MassBio recognized two biopharma companies for scientific and business successes and three leaders in research …See details»
DNA organization offers clues for advancing stem cell therapy
4 days ago DNA organization offers clues for advancing stem cell therapy. by Iqbal Pittalwala, University of California - Riverside. Stem cells (shown as small balls) can be imagined to roll …See details»
NEWS | Waypoint
Waypoint Bio harnesses high throughput and high resolution technologies to advance cell therapy, compressing years of work into a single experiment.See details»
Waypoint Bio Launches with $14.5M to Turbocharge Drug …
Jun 28, 2024 The FDA recently approved the first ever cell therapy for solid tumors, yet innovation in this area has been slow given the challenges of the solid tumor …See details»